Tuvonralimab
Product Specifications
CAS Number
2417649-44-4
Target
PD-1/PD-L1
Related Pathways
Immunology/Inflammation, Apoptosis, Cell Cycle/Checkpoint
Bioactivity
Tuvonralimab (PSB-205; QL1706), comprising a combination of Iparomlimab and Tuvonralimab [1], functions as a dual immune checkpoint inhibitor through its formulation of anti-PD-1 IgG4 and anti-CTLA-4 IgG1 antibodies.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2608714-01 48 Well
Bovine alveoli basement membrane zone antibody(ABM-Ab) ELISA Kit
Sign In for Pricing
View Details MBS2608714-02 96 Well
Bovine alveoli basement membrane zone antibody(ABM-Ab) ELISA Kit
Sign In for Pricing
View Details MBS2608714-03 5x 96 Well
Bovine alveoli basement membrane zone antibody(ABM-Ab) ELISA Kit
Sign In for Pricing
View Details